RSS   Newsletter   Contact   Advertise with us
Post Online Media

Veracyte announces changes to its board of directors

VeracyteVeracyte, a genomic diagnostics company, announced that Kevin K. Gordon, former COO of Quintiles Transnational Holdings, has been appointed to its board of directors.

Mr. Gordon served as executive vice president and COO of Quintiles, a global bio-pharmaceutical services provider, from October 2015 until its merger with IMS Health in October 2016.

READ MORE Veracyte CFO Shelly D. Guyer resigns

He served as the company's executive vice president and chief financial officer from 2010 to 2015.

Prior to that, Mr. Gordon spent 13 years in senior leadership positions at Teleflex Incorporated, a diversified global company, serving most recently as CFO. He previously held senior management positions at KPMG.

Veracyte also announced that Brian Atwood, who has served as director and chairman since the company's founding, has elected to step down from the board.

Concurrently, Bonnie Anderson, Veracyte's president and chief executive officer, has assumed the additional role of chairman of the board and John L. Bishop will become the lead independent director.




What to read next



 LATEST MOVES FROM California 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy